0001104659-20-135877.txt : 20201215
0001104659-20-135877.hdr.sgml : 20201215
20201215192524
ACCESSION NUMBER: 0001104659-20-135877
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201215
FILED AS OF DATE: 20201215
DATE AS OF CHANGE: 20201215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gibson Robert J
CENTRAL INDEX KEY: 0001821615
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39788
FILM NUMBER: 201390871
MAIL ADDRESS:
STREET 1: 71 LANTERN RIDGE RD
CITY: NEW CANAAN
STATE: CT
ZIP: 06840
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Scopus BioPharma Inc.
CENTRAL INDEX KEY: 0001772028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821248020
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 LEXINGTON AVENUE, SUITE 300
CITY: NEW YORK
STATE: NY
ZIP: 10170
BUSINESS PHONE: (212) 479-2513
MAIL ADDRESS:
STREET 1: 420 LEXINGTON AVENUE, SUITE 300
CITY: NEW YORK
STATE: NY
ZIP: 10170
FORMER COMPANY:
FORMER CONFORMED NAME: Scopus Biopharma Inc.
DATE OF NAME CHANGE: 20190327
3
1
tm2038482-4_3.xml
OWNERSHIP DOCUMENT
X0206
3
2020-12-15
0
0001772028
Scopus BioPharma Inc.
SCPS
0001821615
Gibson Robert J
C/O SCOPUS BIOPHARMA INC.
420 LEXINGTON AVENUE, SUITE 300
NEW YORK
NY
10170
1
1
0
0
Vice Chairman
Common Stock, par value $0.001
2000
D
Common Stock, par value $0.001
210052
I
Dayber Snow LLC
Common Stock, par value $0.001
200000
I
HCFP/Capital Partners 18B-1 LLC
W Warrant
4.00
2021-10-01
2026-09-30
B Unit
6668
I
Dayber Snow LLC
W Warrant
4.00
2021-10-01
2026-09-30
B Unit
769500
I
HCFP/Capital Partners 18B-2 LLC
Includes an aggregate of 2,000 shares held by Mr. Gibson's minor children.
Includes shares held by Dayber Snow LLC, of which Mr. Gibson is a member and co-manager. Accordingly, he is deemed to have shared voting and dispositive power over the shares held by this entity.
Does not have voting or dispositive power over the shares held by this entity. Mr. Gibson disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein.
Each W Warrant is exercisable for one B Unit. Starting on April 1, 2022, each B Unit can be separated into one share of common stock and one Z Warrant. Each Z warrant is exercisable for one share of common stock with an exercise price of $5.00 per share. The Z Warrant will become exercisable on July 1, 2022 and will expire on June 30, 2027.
Includes securities held by Dayber Snow LLC, of which Mr. Gibson is a member and co-manager, and HCFP/Capital Partners 18B-2 LLC, over which securities Mr. Gibson does not have voting or dispositive power. Accordingly, he is deemed to have shared voting and dispositive power and no voting and dispositive power over the securities held by Dayber Snow LLC and HCFP/Capital Partners 18B-2 LLC, respectively. Mr. Gibson disclaims beneficial ownership of securities held by these entities, except to the extent of his proportionate pecuniary interest therein.
/s/ Robert J. Gibson
2020-12-15